Clinical Trial Update: Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 randomized study of ATN-224 in combination with temozolomide in advanced melanoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ATN-224
• Temozolomide (Temozolomide)

Snippet

Sponsor: Attenuon | Conditions: Melanoma | Phase 2 | Status: UNKNOWN